Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett P Monia

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Diabetes|July 30, 2002
Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesisCristina M Rondinone, James M Trevillyan, Jill Clampit, et al.
The Journal of Clinical Investigation|August 1, 2006
Antisense oligonucleotide therapy for neurodegenerative diseaseRichard A Smith, Timothy M Miller, Koji Yamanaka, et al.
The Journal of Clinical Investigation|February 18, 2006
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2David B Savage, Cheol Soo Choi, Varman T Samuel, et al.
Blood Advances|October 25, 2019
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT miceToshiaki Shirai, Alexey S Revenko, Justin Tibbitts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Blood Advances|June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermediaAli Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Cancer Research|May 4, 2019
Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune EvasionYi Yang, Amanda Stang, Patrick G Schweickert, et al.
Endocrinology|January 24, 2009
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeysMichael M Swarbrick, Peter J Havel, Arthur A Levin, et al.
Nucleic Acid Therapeutics|March 1, 2019
IONIS-PKK<sub>Rx</sub> a Novel Antisense Inhibitor of Prekallikrein and Bradykinin ProductionJason D Ferrone, Gourab Bhattacharjee, Alexey S Revenko, et al.
Nucleic Acid Therapeutics|May 23, 2013
Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeysSebastien A Burel, So-Ri Han, Hong-Soo Lee, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Diabetes|July 30, 2002
Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesisCristina M Rondinone, James M Trevillyan, Jill Clampit, et al.
The Journal of Clinical Investigation|August 1, 2006
Antisense oligonucleotide therapy for neurodegenerative diseaseRichard A Smith, Timothy M Miller, Koji Yamanaka, et al.
The Journal of Clinical Investigation|February 18, 2006
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2David B Savage, Cheol Soo Choi, Varman T Samuel, et al.
Blood Advances|October 25, 2019
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT miceToshiaki Shirai, Alexey S Revenko, Justin Tibbitts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Blood Advances|June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermediaAli Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Cancer Research|May 4, 2019
Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune EvasionYi Yang, Amanda Stang, Patrick G Schweickert, et al.
Endocrinology|January 24, 2009
Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeysMichael M Swarbrick, Peter J Havel, Arthur A Levin, et al.
Nucleic Acid Therapeutics|March 1, 2019
IONIS-PKK<sub>Rx</sub> a Novel Antisense Inhibitor of Prekallikrein and Bradykinin ProductionJason D Ferrone, Gourab Bhattacharjee, Alexey S Revenko, et al.
Nucleic Acid Therapeutics|May 23, 2013
Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeysSebastien A Burel, So-Ri Han, Hong-Soo Lee, et al.
Pageof 15